CO49 Evaluating Efficacy and Safety of RNA Therapies Lumasiran and Nedosiran in Patients With Primary Hyperoxaluria Type 1: A Systematic Literature Review
Dec 1, 2024, 00:00
10.1016/j.jval.2024.10.126
https://www.valueinhealthjournal.com/article/S1098-3015(24)02989-9/fulltext
Title :
CO49 Evaluating Efficacy and Safety of RNA Therapies Lumasiran and Nedosiran in Patients With Primary Hyperoxaluria Type 1: A Systematic Literature Review
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)02989-9&doi=10.1016/j.jval.2024.10.126
First page :
Section Title :
Open access? :
No
Section Order :
10710